Expression of human β-defensins HBD-1, HBD-2, and HBD-3 in cultured keratinocytes and skin substitutes

Burns

Volumn 30, Issue 7, 2004, Pages 643-648

  Supp, Dorothy M ^a,b   Karpinski, Andrea C ^a   Boyce, Steven T ^a,b  

^a SHRINERS HOSPITALS FOR CHILDREN   (United States)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

Cultured skin substitutes; Defensins; Keratinocyte; Skin

Indexed keywords

BETA DEFENSIN 1; BETA DEFENSIN 2; BETA DEFENSIN 3;

ADOLESCENT; ADULT; ARTICLE; BURN; CELL CULTURE; CHILD; CONTROLLED STUDY; CORRELATION ANALYSIS; DONOR; EPIDERMIS; FEMALE; GENETIC ANALYSIS; HOST RESISTANCE; HUMAN; HUMAN CELL; HUMAN TISSUE; KERATINOCYTE; MALE; PATIENT; PROTEIN CONTENT; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SKIN GRAFT; UPREGULATION;

ADOLESCENT; ADULT; BETA-DEFENSINS; BURNS; CELLS, CULTURED; CHILD; CHILD, PRESCHOOL; FEMALE; GENE EXPRESSION; HUMANS; INFANT; KERATINOCYTES; MALE; MIDDLE AGED; RNA, MESSENGER; SKIN; SKIN TRANSPLANTATION; SKIN, ARTIFICIAL;

EID: 4744345248     PISSN: 03054179     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.burns.2004.03.012     Document Type: Article

References (36)

1. Boyce S.T., Goretsky M.J., Greenhalgh D.G., Kagan R.J., Rieman M.T., Warden G.D. Comparative assessment of cultured skin substitutes and native skin autograft for treatment of full-thickness burns. Ann Surg. 222(6):1995;743-752
2. Boyce S.T., Kagan R.J., Yakuboff K.P., Meyer N.A., Rieman M.T., Greenhalgh D.G., et al. Cultured skin substitutes reduce donor skin harvesting for closure of excised, full-thickness burns. Ann Surg. 235:2002;269-279
3. Harriger M.D., Warden G.D., Greenhalgh D.G., Kagan R.J., Boyce S.T. Pigmentation and microanatomy of skin regenerated from composite grafts of cultured cells and biopolymers applied to full-thickness burn wounds. Transplantation. 59:1995;702-707
4. Boyce S.T., Harriger M.D., Supp A.P., Warden G.D., Holder I.A. Effective management of microbial contamination in cultured skin substitutes after grafting to athymic mice. Wound Rep Reg. 5:1997;191-197
5. Raj P.A., Dentino A.R. Current status of defensins and their role in innate and adaptive immunity. FEMS Micro Lett. 206:2002;9-18
6. Ganz T., Lehrer R.I. Antimicrobial peptides of vertebrates. Curr Opin Immunol. 10:1998;41-44
7. Bals R. Epithelial antimicrobial peptides in host defense against infection. Respir Res. 1:2000;141-150
8. Ganz T., Lehrer R.I. Antibiotic peptides from higher eukaryotes: biology and applications. Mol Med Today. 5:1999;292-297
9. Takemura H., Kaku M., Kohno S., Hirakata Y., Tanaka H., Yoshida R., et al. Evaluation of susceptibility of Gram-positive and -negative bacteria to human defensins by using radial diffusion assay. Antimicrob Agents Chemother. 40:1996;2280-2284
10. Bals R., Want X., Wu Z., Freeman T., Bafna V., Zasloff M., et al. Human beta-defensin 2 is a salt-sensitive peptide antibiotic expressed in human lung. J Clin Invest. 102:1998;874-880
11. Liu A.Y., Destoumieux D., Wong A.V., Park C.H., Valore E.V., Liu L., et al. Human beta-defensin-2 production in keratinocytes is regulated by interleukin-1, bacteria, and the state of differentiation. J Invest Dermatol. 118:2002;275-281
12. Burd R.S., Furrer J.L., Sullivan J., Smith A.L. Murine beta-defensin-3 is an inducible peptide with limited tissue expression and broad-spectrum antimicrobial activity. Shock. 18:2002;461-464
13. Welling M.W., Hiemstra P.S., van den Barselaar M.T., Paulusma-Annema A., Nibbering P.H., Pauwels E.K.J., et al. Antibacterial activity of human neutrophil defensins in experimental infections in mice is accompanied by increased leukocyte accumulation. J Clin Invest. 102:1998;1583-1590
14. Harder J., Bartels J., Christophers E., Schroder J.-M. Isolation and characterization of human beta-defensin-3, a novel human inducible peptide antibiotic. J Biol Chem. 276:2001;5707-5713
15. Lehrer R.I., Barton A., Daher K.A., Harwig S.S.L., Ganz T., Selsted M.E. Interaction of human defensins with Escherichia coli: mechanism of bactericidal activity. J Clin Invest. 84:1989;553-561
16. Zhao C., Wang I., Lehrer R.I. Widespread expression of beta-defensin hBD-1 in human secretory glands and epithelial cells. FEBS Lett. 396:1996;319-322
17. O'Neil D.A., Porter E.M., Elewaut D., Anderson G.M., Eckmann L., Ganz T., et al. Expression and regulation of human beta-defensins hBD-1 and hBD-2 in intestinal epithelium. J Immunol. 163:1999;6718-6724
18. Singh P.K., Jia H.P., Wiles K., Hesselbert J., Liu L., Conway B.A., et al. Production of beta-defensins by human airway epithelia. Proc Natl Acad Sci U.S.A. 95:1998;14961-14966
19. Fulton C., Anderson G.M., Zasloff M., Bull R., Quinn A.G. Expression of natural peptide antibiotics in human skin. Lancet. 350:1997;1750-1751
20. Ali R.S., Falconer A., Ikram M., Bissett C.E., Cerio R., Quinn A.G. Expression of the peptide antibiotics human beta defensin-1 and human beta defensin-2 in normal human skin. J Invest Dermatol. 117:2001;106-111
21. Milner S.M., Ortega M.R. Reduced antimicrobial peptide expression in human burn wounds. Burns. 25:1999;411-413
22. Nomura I., Goleva E., Howell M.D., Hamid Q.A., Ong P.Y., Hall C.F., et al. Cytokine milieu of atopic dermatitis, as compared to psoriasis, skin prevents induction of innate immune response genes. J Immunol. 171:2003;3262-3269
23. Boyce S.T., Ham R.G. Cultivation, frozen storage, and clonal growth of normal human epidermal keratinocytes in serum-free media. J Tiss Cult Meth. 9:1985;83-93
24. Boyce ST. Methods for serum-free culture of keratinocytes and transplantation of collagen-GAG based composite grafts. In: Morgan JR, Yarmush M, editors. Methods in tissue engineering. Totowa, NJ: Humana Press Inc.; 1998. p. 365.
25. Boyce S.T., Kagan R.J., Meyer N.A., Yakuboff K.P., Warden G.D. The 1999 Clinical Research Award. Cultured skin substitutes combined with Integra to replace native skin autograft and allograft for closure of full-thickness burns. J Burn Care Rehabil. 20:1999;453-461
26. Swope V.B., Supp A.P., Greenhalgh D.G., Warden G.D., Boyce S.T. Expression of insulin-like growth factor-I by cultured skin substitutes does not replace the physiologic requirement for insulin in vitro. J Invest Dermatol. 116:2001;650-657
27. Pruitt B.A. Jr., McManus A.T., Kim S.H., Goodwin C.W. Burn wound infections: current status. World J Surg. 22:1998;135-145
28. Cook N. Methicillin-resistant Staphylococcus aureus versus the burn patient. Burns. 24:1998;91-98
29. Ortega M.R., Ganz T., Milner S.M. Human beta defensin is absent in burn blister fluid. Burns. 26:2000;724-726
30. Nguyen T.T., Gilpin D.A., Meyer N.A., Herndon D.N. Current treatment of severely burned patients. Ann Surg. 223:1996;14-25
31. Erdag G., Morgan J.R. Interleukin-1alpha and Interleukin-6 enhance the antibacterial properties of cultured composite keratinocyte grafts. Ann Surg. 235:2002;113-124
32. Boyce S.T., Supp A.P., Swope V.B., Warden G.D. Vitamin C regulates keratinocyte viability, epidermal barrier, and basement membrane formation in vitro, and reduces wound contraction after grafting of cultured skin substitutes. J Invest Dermatol. 118:2002;565-572
33. Bals R., Weiner D.J., Moscioni A.D., Meegalla R.L., Wilson J.M. Augmentation of innate host defense by expression of a cathelicidin antimicrobial peptide. Infect Immun. 67:1999;6084-6089
34. Bals R., Weiner D.J., Meegalla R.L., Wilson J.M. Transfer of a cathelicidin peptide antibiotic gene restores bacterial killing in a cystic fibrosis xenograft model. J Clin Invest. 103:1999;1113-1117
35. Huang G.T.-J., Zhang H.-B.K.D., Liu L., Ganz T. A model for antimicrobial gene therapy: demonstration of human beta-defensin 2 antimicrobial activities in vivo. Hum Gene Ther. 13:2002;2017-2025
36. Chalekson C.P., Neumeister M.W., Jaynes J. Improvement in burn wound infection and survival with antimicrobial peptide D2A21 (Demegel). Plast Reconstr Surg. 109:2002;1338-1343